ARCHIVES

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

This article is from The Cancer Letter archive.

Vol. 15 No. 46 | December 1, 1989

Download PDF Visit The Full Archive

Related Articles

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

President Requests Extra $200 Million For NIH

March 7, 2014

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003